FindTrial
Sign In

Relation between multi-gene mutation and in immune microenviroment in colorectal cancer

Relation between multi-gene mutation and in immune microenviroment in colorectal cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063396
Enrollment
Unknown
Registered
2022-09-06
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

NA:No

Sponsors

The General Hospital of the People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Age over 18 2. Pathologically confirmed colorectal cancer 3. Resection of colorectal cancer 4. Receiving or not receiving postoperative adjuvant chemotherapy

Exclusion criteria

Exclusion criteria: 1. Colorectal cancer has metastasized 2. Combined with other malignant tumors 3. Receiving neoadjuvant chemotherapy 4. Receiving radiation therapy 5. Receiving targeted drug therapy 6. unable to follow up

Design outcomes

Primary

MeasureTime frame
Whole exome;PFS;—

Countries

China

Contacts

Public ContactShunchang Jiao

The General Hospital of the People's Liberation Army

jiaosc@vip.sina.com+86 10 66939761

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026